Tag Archives: American Medical Association

Bipartisan Group of Senators Introduce MEDS Act

Schatz_Brian_small
Sen. Brian Schatz from his website. Photo above is of Senator Hatch in front of the Capital

This week four Senators introduced the the MEDS Act to streamline the process of approving any medicine derived from the cannabis plant.  Senator Chris Coons of Delaware, Senator Orrin Hatch of Utah (shown above), Senator Brian Schatz of Hawaii and Senator Thom Tillis of North Carolina introduced the Marijuana Effective Drug Studies Act (MEDS) of 2016.

The MEDS Act offers comprehensive, responsible solutions instead of “medicine by ballot initiative,” or the poorly-designed CARERS Act.

Senator Brian Schatz of Hawaii explains: “The MEDS Act will remove excessive barriers that make it difficult for researchers to study the effectiveness and safety of marijuana, and hopefully, give patients more treatment options.”

Senator Thom Tillis of North Carolina said: “The MEDS Act is a commonsense, bipartisan effort to remove unnecessary barriers that will give scientists the ability to study the biochemical processes, impact, dosing, risks and possible benefits of cannabidiol and other components of the marijuana plant.”

ThomTillis
Sen. Thom Tillis of North Carolina. Photo: Political Insider

As Smart Approaches to Marijuana which supports the bill explains, the bill:

*Enables more research on marijuana by creating a faster, more streamlined process for obtaining approval from the Drug Enforcement Agency (DEA) to conduct research, including the ability to amend and supplement research proposals without reapplying. Currently, researchers who want to conduct research on marijuana must interface with several federal agencies and engage in a complex application process that can take a year or longer must start from scratch if they make any changes to their research proposal;

*Eliminates the burdensome requirement of some DEA field offices that marijuana be kept in bolted safes – a requirement not possible in many research and clinical settings – and codifies current DEA regulations that allow marijuana to be stored in securely locked, substantially constructed cabinets; and

*Requires the licensing of marijuana manufacturers for the purpose of valid scientific and clinical research and drug development and establishes manufacturing licenses for the commercial production of FDA-approved medical marijuana products.

Dr. Kevin Sabet, President of Smart Approaches to Marijuana, said. “Despite state laws, raw marijuana (smoked or ingested) is not medicine, and has never passed through the rigorous FDA approval process to ensure the health and safety of patients.  The plant’s components should be studied so those in need can access any therapeutic benefits while knowing dosage, side effects, and contraindications. And more broadly speaking, the MEDS Act upholds the important, basic principle that all medications-including marijuana-based drugs-should go through the scientific process and accessed through legitimate doctors.”

1394123794000-Chris-Coons-2
Sen. Chris Coons of Delaware. Photo: Getty Images

The American Medical Association, American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Society of Addiction Medicine, American Preventive Medical Association, American Pain Society, American Society of Anesthesiologists, and the American Academy of Pain Medicine in support of the MEDS Act.

We salute the bipartisan nature of this bill.   In the House of Representatives, Rep. Earl Blumenauer of Oregon, Rep. Sam Farr of California, Rep. Morgan Griffith of Virginia and Rep Andy Harris of Maryland are expected to introduce a similar bill.

The MEDS Act represents a great improvement over the CARERS Act.  Three Senators presented the CARERS Act to garner media attention last year.  It was a dramatic gesture.  We live in a time when too many people believe that anything derived from nature, such is poison ivy or snake oil, must be safe because it is “from nature” or “a gift from God.”  Sometimes these purveyors of natural medicine make promises that cannot be kept.

Many states do not keep track of doctors and others who prescribe “medical” marijuana for nebulous reasons.  Other states, such as New Jersey and Illinois, have highly controlled program.

Psychiatric problems that have ballooned in states that give out medical marijuana without reasonable medical purpose, but that can be addressed at a later date.   For this reason a doctor in Florida, is urging residents in his states not to pass Amendment 2.  “The easy access to marijuana has led to exacerbations of chronic health conditions, particularly mental health disease. It is difficult to fully quantify the worsening of psychosis, anxiety, depression and other mental health diseases, but easy access to marijuana and other narcotics makes a bad condition worse.”  warned Dr. Allen Weiss, head of the Naples Health Care System.

Please follow and like us:

Youth Marijuana Use Remains High, Other Drug Use Down

The nation’s annual school survey of drug use, Monitoring the Future (MTF), shows marijuana use among adolescents,
including heavy marijuana use, remaining stubbornly high and significantly higher than in 2008 — despite reductions across the board among the other three substances kids use most.

Daily Pot Use 3x the rate of Daily Alcohol Use Among High School students

In fact, 6 percent of 12th graders are daily marijuana users and 3 percent of 10th graders use pot every day.   For comparison, daily alcohol use among  10th graders is 1/2 of 1%.  Among 12th graders, it is 1.9%, 1/3 the rate of daily pot use. Continue reading Youth Marijuana Use Remains High, Other Drug Use Down

Please follow and like us:

American Epilepsy Association Statement on CBD Oils

The following letter was written by Dr. Amy Brooks-Kayal to a state representative in Pennsylvania.  Here is an article where the letter had been published.

March 22, 2015

Dear Representative,

As Pennsylvania considers enacting new cannabis legislation (HB 193), I write to offer the perspective of the American Epilepsy Society (AES), the leading U.S. organization of clinical and research professionals specializing in the treatment and care of people with epilepsy. Continue reading American Epilepsy Association Statement on CBD Oils

Please follow and like us: